Transient myasthenia gravis in an elderly woman

Wong, W W Y; Lane, R J M
September 2004
Journal of Neurology, Neurosurgery & Psychiatry;Sep2004, Vol. 75 Issue 9, p1363
Academic Journal
case study
The article focuses on a case study dealing with transient myasthenia gravis in an elderly woman. Myasthenia gravis is usually a chronic disorder, although remission rates of 25 percent to 30 percent can be expected with judicious interventions such as thymectomy and immunosuppression in appropriate cases. The patient, a 78 year old woman, developed acute, painless left sided ptosis, while on holiday abroad. There was no diplopia. She had developed hypothyroidism one year before but was euthyroid on replacement therapy.


Related Articles

  • Bilateral internuclear ophthalmoplegia as a false localizing sign. Bakheit, A. M. O.; Behan, P. O.; Melvill, I. D. // Journal of the Royal Society of Medicine;Oct1991, Vol. 84 Issue 10, p627 

    The article presents the case report of a patient with myasthenia gravis (MG). The patient, a 21-year-old man, was presented with a history of diplopia with horizontal separation of images. The neurological examination of the patient showed anterior internuclear ophthalmoplegia. Evidence of...

  • Extended transcervical thymectomy with partial upper sternotomy: results in non-thymomatous patients with myasthenia gravis. Ruffini, Enrico; Guerrera, Francesco; Filosso, Pier Luigi; Bora, Giulia; Nex, Giulia; Gusmano, Simone; Giobbe, Maria Laura; Ciccone, Giovannino; Bruna, Maria Cristina; Giobbe, Roberto; Solidoro, Paolo; Lyberis, Paraskevas; Oliaro, Alberto // European Journal of Cardio-Thoracic Surgery;Sep2015, Vol. 48 Issue 3, p448 

    OBJECTIVES: Thymectomy is a recognized treatment for myasthenia gravis (MG), but the optimal surgical approach is yet to be determined. This study analysed the results in non-thymomatous MG patients treated at our institution using an extended transcervical access with partial upper sternotomy...

  • When the patient fails to respond to treatment: myasthenia gravis. Hilton-Jones, D. // Practical Neurology (BMJ Publishing Group);Dec2007, Vol. 7 Issue 6, p405 

    The article discusses alternative therapeutic strategies when a patient with myasthenia gravis does not respond to treatment. If treatment with azathioprine fails, other immunosuppressive drugs include ciclosporin, cyclophosphamide and methotrexate. Intravenous plasma exchange and immunoglobulin...

  • SELF ASSESSMENT ANSWERS: Acute respiratory failure in a middle aged woman.  // Postgraduate Medical Journal;Oct2001, Vol. 77 Issue 912, p673 

    This article presents several questions and answers related to acute respiratory failure in a middle aged woman. The combination of peripheral and ocular muscle weakness together with the patient's history of other autoimmune conditions would be suggestive of myasthenia gravis as the underlying...

  • Juvenile seropositive myasthenia gravis with anti-MuSK antibody after thymectomy. Kostera-Pruszczyk, Anna; Kwiecinski, Hubert // Journal of Neurology;Oct2009, Vol. 256 Issue 10, p1780 

    We report the case of a 17.5-year old girl with generalized myasthenia gravis (MG). When she was 13, she started to complain of episodic diplopia, ptosis and mild fatigability of upper and lower extremity muscles. She was diagnosed with MG 3 years later, after exacerbation of her limb muscle...

  • Successful low-dose azathioprine for myasthenia gravis despite hepatopathy from primary sclerosing cholangitis: a case report. Finsterer, Josef; Höflich, Sonja // Journal of Medical Case Reports;2010, Vol. 4 Issue 1, p1 

    Introduction: Although myasthenia gravis is frequently associated with other disorders, it has not been reported together with primary sclerosing cholangitis, complicating the administration of liver-toxic immunosuppressive therapy. Case presentation: A 73-year-old Caucasian woman with a history...

  • The natural course of myasthenia gravis. Fonseca, V.; Havard, C.W.H. // BMJ: British Medical Journal (International Edition);6/2/90, Vol. 300 Issue 6737, p1409 

    Examines the use of thymectomy, corticosteroid and immunosuppressive agents in the treatment of myasthenia gravis in Great Britain. Reduction of morbidity; Requirement of long duration of treatment; Beneficial effects of the drugs.

  • Robotic-Assisted Thymectomy in Patients with Nonthymomatous Myasthenia Gravis. Al-Githmi, Iskander // Surgical Science;Sep2011, Vol. 2 Issue 7, p393 

    Complete removal of the thymus and fatty tissue adherent to pericardium is crucial for treating myasthenia gravis. Our aim was to analyze our surgical and clinical results and early experience of robot-assisted thymectomy in patients with nonthymomatous myasthenia gravis. Between January 2008...

  • Thymectomy in myasthenia gravis. Murthy, J. M. K. // Neurology India;Jul2009, Vol. 57 Issue 4, p363 

    The article discusses the use of thymectomy in myasthenia gravis (MG). This condition is an autoimmune disorder of the neuromuscular junction characterized by skeletal muscle weakness. Using thymectomy in MG is on the basis of circumstantial evidence and expert opinion. It was found that...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics